All data are based on the daily closing price as of April 10, 2026
s
Sunmax Biotechnology
4728.TWO
12.11 USD
-0.04
-0.33%
Overview
Last close
12.11 usd
Market cap
659.33M usd
52 week high
16.58 usd
52 week low
7.93 usd
Target price
N/A usd
Valuation
P/E
28.9098
Forward P/E
N/A
Price/Sales
10.3353
Price/Book Value
12.9444
Enterprise Value
632.83M usd
EV/Revenue
9.9196
EV/EBITDA
17.917
Key financials
Revenue TTM
63.80M usd
Gross Profit TTM
50.02M usd
EBITDA TTM
33.68M usd
Earnings per Share
0.42 usd
Dividend
0.38 usd
Total assets
67.65M usd
Net debt
N/A usd
About
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.